Metastatic disease in the thoracic and lumbar spine: Evaluation and management

Peter S. Rose; Jacob M. Buchowski

Metastatic disease in the thoracic and lumbar spine: Evaluation and management

Research output: Contribution to journal › Review article › peer-review

Abstract

Spinal metastases are found in most patients who die of cancer. The number of patients with symptomatic spinal metastases likely will increase as therapy for the primary disease improves and as cardiovascular mortality decreases. Understanding the epidemiology of metastatic spine disease and its presentation is essential to developing a diagnostic strategy. Treatment may involve chemotherapy, corticosteroids, radiotherapy, surgery, and/or percutaneous procedures (eg, vertebroplasty, kyphoplasty). A rational treatment plan can help improve quality of life, preserve neurologic function, and prolong survival.

Original language	English
Pages (from-to)	37-46
Number of pages	10
Journal	Journal of the American Academy of Orthopaedic Surgeons
Volume	19
Issue number	1
State	Published - Jan 1 2011

Access to Document

Link to publication in Scopus

Fingerprint Dive into the research topics of 'Metastatic disease in the thoracic and lumbar spine: Evaluation and management'. Together they form a unique fingerprint.

Cite this

@article{3a02cafe1a7642d4a6dd12247cbca0b7,

title = "Metastatic disease in the thoracic and lumbar spine: Evaluation and management",

abstract = "Spinal metastases are found in most patients who die of cancer. The number of patients with symptomatic spinal metastases likely will increase as therapy for the primary disease improves and as cardiovascular mortality decreases. Understanding the epidemiology of metastatic spine disease and its presentation is essential to developing a diagnostic strategy. Treatment may involve chemotherapy, corticosteroids, radiotherapy, surgery, and/or percutaneous procedures (eg, vertebroplasty, kyphoplasty). A rational treatment plan can help improve quality of life, preserve neurologic function, and prolong survival.",

author = "Rose, {Peter S.} and Buchowski, {Jacob M.}",

year = "2011",

month = jan,

day = "1",

language = "English",

volume = "19",

pages = "37--46",

journal = "Journal of the American Academy of Orthopaedic Surgeons",

issn = "1067-151X",

number = "1",

}

TY - JOUR

T1 - Metastatic disease in the thoracic and lumbar spine

T2 - Evaluation and management

AU - Rose, Peter S.

AU - Buchowski, Jacob M.

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Spinal metastases are found in most patients who die of cancer. The number of patients with symptomatic spinal metastases likely will increase as therapy for the primary disease improves and as cardiovascular mortality decreases. Understanding the epidemiology of metastatic spine disease and its presentation is essential to developing a diagnostic strategy. Treatment may involve chemotherapy, corticosteroids, radiotherapy, surgery, and/or percutaneous procedures (eg, vertebroplasty, kyphoplasty). A rational treatment plan can help improve quality of life, preserve neurologic function, and prolong survival.

AB - Spinal metastases are found in most patients who die of cancer. The number of patients with symptomatic spinal metastases likely will increase as therapy for the primary disease improves and as cardiovascular mortality decreases. Understanding the epidemiology of metastatic spine disease and its presentation is essential to developing a diagnostic strategy. Treatment may involve chemotherapy, corticosteroids, radiotherapy, surgery, and/or percutaneous procedures (eg, vertebroplasty, kyphoplasty). A rational treatment plan can help improve quality of life, preserve neurologic function, and prolong survival.

UR - http://www.scopus.com/inward/record.url?scp=78951470020&partnerID=8YFLogxK

M3 - Review article

C2 - 21205766

AN - SCOPUS:78951470020

VL - 19

SP - 37

EP - 46

JO - Journal of the American Academy of Orthopaedic Surgeons

JF - Journal of the American Academy of Orthopaedic Surgeons

SN - 1067-151X

IS - 1

ER -